← Leaderboards
Mary Ann Degroote
Crestone, Inc.
$813,744
Attributed
$1,627,487
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $761.4K · FY2014–16$1M$750K$500K$250K$0
'14
'15
'16
Funding mix
By agency
NIH$1,627,487 · 2
By mechanism
R44$1,477,487 · 1
R43$150,000 · 1
Top collaborators
- Thale Cross Jarvis2 shared
- Xicheng Sun1 shared
Most similar at Crestone, Inc.
Same institution · by research overlap
- Thale Cross Jarvis$6,890,861
- Xicheng Sun$358,031
Others in their field
Top investigators on “Immunosuppressive Agents”
- Joren C Madsen · Massachusetts General Hospital$35,294,102
- Allan D. Kirk · Emory University$32,679,021
- Janet T. Holbrook · Johns Hopkins University$27,989,683
- Peter G Stock · University Of California San Francisco$27,957,533
- Daniel F. Hoft · Saint Louis University$26,271,892
- Christian P Larsen · Emory University$22,006,398
Research focus
Immunosuppressive AgentsIn VivoExhibitsHemolysisInhibitor/AntagonistIn VitroDrug DiscoveryEpidemiologyClinically RelevantGram-Negative BacteriaDoseInfectionAntimicrobial DrugCytotoxicityAntimycobacterial AgentsCystic FibrosisAnti-Bacterial AgentsDrug KineticsCellsAntibioticsBaseGenus MycobacteriumAnalogLead